Regulation of TNF-α by 1α,25-dihydroxyvitamin D3 in human macrophages from CAPD patients

Manolagas, 1985, Interaction of 1,25-dihydroxyvitamin D3 and the immune system, Mol Cell Endocrinol, 43, 113, 10.1016/0303-7207(85)90074-7 Kelsey, 1989, Annotation vitamin D and human leukemia, Br J Haematol, 71, 173, 10.1111/j.1365-2141.1989.tb04250.x Abe, 1981, Differentiation of mouse myeloid leukemia cells induced by 1,25-dihydroxyvitamin D3, Proc Natl Acad Sci USA, 78, 4990, 10.1073/pnas.78.8.4990 Shany, 1991, Metabolism of 25-OH-vitamin D3 by peritoneal macrophages from CAPD patients, Kidney Int, 39, 1005, 10.1038/ki.1991.127 Aloni, 1983, Losses of 25-hydroxyvitamin D in peritoneal fluid: peritoneal dialysis, Miner Electrolyte Metab, 9, 82 Deutsch, 1995, Elevated superoxide generation in mononuclear phagocytes by treatment with 1 alpha hydroxyvitamin D3: changes in kinetics and in oxidase cytosolic factor p47, J Am Soc Nephrol, 6, 102, 10.1681/ASN.V61102 Binderup, 1992, Immunological properties of vitamin D analogues and metabolites, Biochem Pharmacol, 43, 1885, 10.1016/0006-2952(92)90630-2 Shany, 1995, Of 1,25-dihydroxyvitamin D on the immune activity of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients, Nephron, 69, 367, 10.1159/000188504 Rigby, 1987, Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3: Specific inhibition at the level of messenger RNA, J Clin Invest, 79, 1659, 10.1172/JCI113004 Prehn, 1992, Potentiation of lipopolysaccharide-induced tumor necrosis factor-alpha expression by 1,25-dihydroxyvitamin D3, Blood, 80, 2811, 10.1182/blood.V80.11.2811.2811 Bhalla, 1986, Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 production, Cell Immunol, 98, 311, 10.1016/0008-8749(86)90291-1 Fagan, 1991, The human myelomonocytic cell line U-937 as a model for studying alterations in steroid-induced monokine gene expression: marked enhancement of lipopolysaccharide-stimulated interleukin-1 beta messenger RNA levels by 1,25-dihydroxyvitamin D3, Mol Endocrinol, 5, 179, 10.1210/mend-5-2-179 Furman, 1996, Differential expression of M-CSF, LIF, and TNF-alpha genes in normal and malignant rat glial cells: Regulation by lipopolysaccharide and vitamin D, J Neurosci Res, 46, 360, 10.1002/(SICI)1097-4547(19961101)46:3<360::AID-JNR9>3.0.CO;2-I D'Ambrosio, 1998, Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3: Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene, J Clin Invest, 101, 252, 10.1172/JCI1050 Riancho, 1993, Vitamin D therapy modulates cytokine secretion in patients with renal failure, Nephron, 65, 364, 10.1159/000187514 Panichi, 1998, Calcitriol modulates in vivo and in vitro cytokine production: A role for intracellular calcium, Kidney Int, 54, 1463, 10.1046/j.1523-1755.1998.00152.x Goldstein, 1984, Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients, Kidney Int, 26, 733, 10.1038/ki.1984.209 Levy, 1990, Diversity in peritoneal macrophage response of CAPD patients to 1,25-dihydroxyvitamin D3, Kidney Int, 37, 1310, 10.1038/ki.1990.116 Bouaboula, 1992, Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control, J Biol Chem, 267, 21830, 10.1016/S0021-9258(19)36687-6 Legoux, 1992, Simultaneous quantitation of cytokine mRNAs in interleukin-1 beta stimulated U373 human astrocytoma cells by a polymerisation chain reaction method involving co-amplification with an internal multi-specific control, Eur Cytokine Netw, 3, 553 Reinhardt, 1984, A micro-assay for 1,25(OH)2D3, not requiring HPLC: Applications to clinical studies, J Clin Endocrinol Metab, 58, 91, 10.1210/jcem-58-1-91 Shany, 1993, Subcellular localization and partial purification of the 25-hydroxyvitamin D3, 1-hydroxylation reaction in the chick myelomonoctytic cell line HD-11, J Bone Miner Res, 8, 269, 10.1002/jbmr.5650080304 Rigby, 1988, The immunobiology of vitamin D, Immunol Today, 9, 54, 10.1016/0167-5699(88)91260-1 Andreoli, 1994, Mechanisms of polymorphonuclear leukocyte mediated peritoneal mesothelial cell injury, Kidney Int, 46, 1100, 10.1038/ki.1994.372 Collart, 1990, Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B, Mol Cell Biol, 10, 1498 Shany, 1984, Losses of 1, 25 and 24: 25-dihydroxycholecaliferol in the peritoneal fluid of patients treated with chronic ambulatory dialysis, Nephron, 36, 111, 10.1159/000183128 Old, 1985, Tumor necrosis factor (TNF), Science, 230, 630, 10.1126/science.2413547 Beutler, 1986, Cachectin and tumour necrosis factor as two sides of the same biological coin, Nature, 320, 584, 10.1038/320584a0 Tracey, 1988, Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation, J Exp Med, 167, 1211, 10.1084/jem.167.3.1211 Piguet, 1987, Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease, J Exp Med, 166, 1280, 10.1084/jem.166.5.1280 Held, 1990, Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes, Proc Natl Acad Sci USA, 87, 2239, 10.1073/pnas.87.6.2239 Elliott, 1994, Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis, Lancet, 334, 1105, 10.1016/S0140-6736(94)90628-9 Elliott, 1994, Replaced therapy with monoclonal antibody to tumor necrosis factor alpha (cA2) in patients with rheumatoid arthritis, Lancet, 344, 1125, 10.1016/S0140-6736(94)90632-7 Koffler, 1985, 1,25-Dihydroxyvitamin D3: In vivo and in vitro effects on human preleukemic and leukemic cells, Cancer Treat Rep, 69, 1399 Levy, 1998, The novel analog 1,24(S)-Dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines, Anticancer Res, 18, 1769 Knutson, 1997, Pharmacokinetics and systemic effect on calcium homeostasis of 1 alpha,24-dihydroxyvitamin D2 in rats: Comparison with 1 alpha,25-dihydroxyvitamin D2, calcitriol, and calcipotriol, Biochem Pharmacol, 53, 829, 10.1016/S0006-2952(97)00004-X